- OTHM Level 7 Diploma Unit Globalisation and Corporate Governance (L/616/2730) Assessment Brief 2026
- OTHM Level 7 Diploma Unit Strategic Change Management (R/616/2731) Assessment Brief 2026
- Qualifi Level 6 Diploma Unit BA603 Strategic Marketing Management (603/1037/6) Assignment Brief 2026
- 4005NAPRN Promoting Health and Preventing Ill Health Assignment 2026 | LJMU
- CIPD Level 3 Unit 3CO04 Essentials of People Practice Assignment Example 2026
- CIPD Level 3 Unit 3CO03 Core Behaviours for People Professionals Assignment Example 2026
- CIPD Level 3 Unit 3CO02 Principles of Analytics Assessment Example 2026
- CIPD Level 3 Unit 3CO01 Business, Culture and Change in Context Assessment Example 2026
- OTHM Level 7 Diploma Unit Supply Chain and Operations Management (R/616/2728) Assignment Brief 2026
- PSYM221Z Introduction to Statistics Summative Assessment 2, 2026 | University of Exeter
- SH4012QA Human Growth & Development Assessment Brief 2026 | LMU
- OTHM Level 7 Diploma Unit Strategic Marketing (Y/616/2732) Assignment Brief 2026
- OTHM Level 7 Diploma Unit Strategic Financial Management (L/616/2727) Assignment Brief 2026
- OTHM Level 7 Diploma Unit Advanced Business Research Methods (J/616/2726) Assignment Brief 2026
- OTHM Level 7 Diploma Unit Strategic Human Resource Management (F/616/2725) Assignment Brief 2026
- OTHM Level 7 Diploma Unit Strategic Leadership (R/617/5012) Assignment Brief 2026
- OTHM Level 7 Diploma Unit Strategic Management (A/616/2724) Assignment Brief 2026
- MIDP4100 Midwife as Scholar 1 Assessment Brief 2026 | University of Cumbria
- OTHM Level 7 Diploma Unit Entrepreneurship and Innovation ( Y/616/2729 ) Assignment Brief 2026
- ILM Level 3 Unit 303 Reflecting on Coaching Skills within an Organisational Context (M/617/2845) Assessment Brief 2026
You are working within the pharmaceutical industry, and you have been assigned a kinase to develop an inhibitor for: Medicinal Chemistry Assignment, UniS, UK
| University | University Of Surrey (UniS) |
| Subject | Medicinal Chemistry |
You are working within the pharmaceutical industry, and you have been assigned a kinase to develop an inhibitor for. Your team has already found a compound that can moderate the activity of the kinase of interest.
- Using this information, use AutoDockTools and Autodock Vina to dock your compound with the kinase of interest. Your report should include
- A brief explanation of how you determine the search area for the docking, accompanied by a suitable picture to show where the search box is located with respect to the kinase in your docking.

You can click “Ligand Interaction” which will bring you to a new page displaying where and how a drug molecule interacts with the kinase. You can use your mouse to rotate and zoom in/out to help you visualize the binding site.
Once you have a good understanding of where the binding site should be, you need to adjust the dimensions, scaling factor, and the center of the search box in AutoDockTools based on this information. You need to make sure you define the search box correctly in your conf.txt file. - Description of possible interactions between your compound and the kinase that you have identified after docking, accompanied by a suitable picture and labeling to highlight the interactions.
- A table to show the binding affinity of your compound and the kinase from docking.
- Based on the results from the molecular docking, and also using your knowledge of medicinal chemistry, make FIVE changes you would make to the molecule in order to probe SAR and increase binding efficiency. Your answer should be a maximum of ONE A4 page in length, should concisely describe why you are making those changes, and should include chemical drawings of your hit compound and subsequent analogs in order to visualize those changes.
Buy Answer of This Assessment & Raise Your Grades
Answer




